LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences Inc. (OTC Bulletin Board: GLIF) announced today that it has signed a final agreement with Alphagenics Diaco Biotechnologies S.r.l. (Italy) to exclusively in-license the manufacturing and marketing rights to Alphagenics’ molecular diagnostic test for human papillomaviruses (HPVs) in China and the United States and non-exclusively in all other countries.
